Navigation Links
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Date:5/11/2009

ors of concern should be reported immediately to healthcare providers.

Medication errors involving Lamictal have occurred. In particular, the name Lamictal or lamotrigine can be confused with the names of other commonly used medications. Medication errors may also occur between the different formulations of Lamictal. To reduce the potential of medication errors, healthcare professionals should write and say Lamictal clearly. Depictions of the Lamictal Tablets, Chewable Dispersible Tablets, and Orally Disintegrating Tablets can be found in the Medication Guide that accompanies the product to highlight the distinctive markings, colors, and shapes that serve to identify the different presentations of the drug and thus may help reduce the risk of medication errors. To avoid the medication error of using the wrong drug or formulation, patients should be strongly advised to visually inspect their tablets to verify that they are Lamictal, as well as the correct formulation of Lamictal, each time they fill their prescription.

Patients should not take Lamictal or Lamictal ODT if they have had an allergic reaction to lamotrigine or to any of the inactive ingredients.

Common side effects include dizziness, headache, blurred or double vision, lack of coordination, sleepiness, nausea, vomiting, insomnia, tremor, rash, fever, abdominal pain, back pain, tiredness, and dry mouth. Patients should tell their healthcare provider about any side effect that bothers them or does not go away; patients should tell their healthcare provider if they have any changes in their menstrual pattern, such as breakthrough bleeding, while taking Lamictal and birth control pills. These are not all the possible side effects of Lamictal.

*Depakene and Depakote are registered trademarks of Abbott Laboratories

For full prescribing
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
2. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
3. FDA Approves Plan B Pill for 17-Year-Olds
4. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
5. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
6. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
7. U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
8. FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
9. FDA Approves Two Hologic HPV Tests
10. U.S. Food and Drug Administration Approves New Female Condom
11. Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... CO (PRWEB) August 27, 2014 For ... to performances by the beloved mantra singers Deva Premal ... Following the release of their latest album in ... touching down in twenty-two countries around the globe, including ... Chile, Argentina and across Europe. With a new album ...
(Date:8/27/2014)... 27, 2014 BESLER Consulting , ... services for hospitals, is pleased to announce that it ... of America’s Fastest-Growing Companies. The list represents the most ... independent entrepreneurs. , "It's been an exciting year ... included in this year's Inc. 5000 list,” said Jonathan ...
(Date:8/27/2014)... AZ (PRWEB) August 27, 2014 ... of in-home care for seniors, is proud to announce ... Series. The upcoming webinar will feature Dr. Suzanne Steinbaum, ... Lenox Hill Hospital in New York City, National Spokesperson ... author. The webinar will cover the issues surrounding women ...
(Date:8/27/2014)... new analysis of clinical trial participation in the largest ... found participants are not representative of the larger patient ... Hospital cardiologist Dr. Jay Udell. The study authors call ... the wider population, and suggest the use of broader ... participation. , "We know that clinical trials can be ...
(Date:8/27/2014)... researchers developed and tested an advanced statistical model ... contribute to disease as published yesterday in ... fills a gap in current analyses. Complex diseases ... genetic and environmental factors. When many such combinations ... that reflect chance combinations among affected individuals becomes ...
Breaking Medicine News(10 mins):Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2
... by a specialty pharmacy program were more compliant with ... for their disease than those who were not managed ... completed by HealthCore, Inc. , HealthCore researcher Jingbo Yu ... Pharmacoeconomic and Outcomes Research 14th Annual International Meeting in ...
... RECORDING OF DAVID COOK,S ,IDOL, PERFORMANCE WILL BE SOLD ... Sale of Live Version of ,Permanent, Will Be Donated ... Exactly one year after winning the seventh season ... popular television series in America on Wednesday night to ...
... the 80th anniversary of The Children,s Center of Wayne ... a Power of Possibilities Breakfast is being held on ... http://www.newscom.com/cgi-bin/prnh/20090423/CCWCLOGO ) Embarking on its ... of founder Senator James Couzens. His intention was ...
... NAPERVILLE, Ill., May 20 Viant, Inc., a leader ... that they have signed an agreement with Tempe, AZ-based ... in the state of Arizona. Viant customers utilizing the ... have access to HMA, Inc.,s Arizona provider networks, which ...
... in Texas. , ... Houston, TX (PRWEB) May ... leading provider of retirement services in the academic, medical research and ... the 2009 TIAA-CREF Distinguished Medical Educator Award ( www.tiaa-crefaward.org ...
... Depression Are Diagnosed by a Physician - Dramatically ... SymptomsORLANDO, Fla., May 20 Whites experiencing depression ... a physician than other ethnic groups, according to ... today at the 14th Annual ISPOR (International Society ...
Cached Medicine News:Health News:MS patients more compliant with medications when managed by specialty pharmacy 2Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:80th Anniversary Power of Possibilities Breakfast Honors the Children's Center of Wayne County 2Health News:Viant Expands Relationship With HMA for Improved Healthcare Access in AZ 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 3Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 4Health News:New Study Reveals Wide Variations in Depression Diagnoses among Ethnic Groups 2
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... -- Reportlinker.com announces that a new market research report ... Eastern Europe 2014 http://www.reportlinker.com/p02312454/Baby-Food-Eastern-Europe-2014.html ... a new report by ERC that analyzes the Baby ... , key segments, features & developments, future projections ... which are currently affecting the industry. Furthermore, it profiles ...
(Date:8/27/2014)... Aug. 27, 2014 North American lighting leader ... 100 Award for the new OSRAM ITOS ® PHASER ... light module for microscopy, endoscopy and surgical head lamps that ... higher efficacy and lamp life. "We,re honored to ... the most innovative new technologies of the past year," said ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... , BASKING RIDGE, N.J., Nov. 11 Regado ... of antithrombotic aptamers with active control agents, announced ... Chief Scientific Officer, will be presenting an abstract ... Center in Philadelphia, Pennsylvania. Dr. Rusconi,s abstract "Aptamer-Active ...
... Recap LLC (Recap) has launched "Development Optimizer," the ... Deloitte. The series of biopharmaceutical business intelligence tools ... toward business development, corporate strategy, financial, clinical development, ... Optimizer" provides flexible analytical tools for biopharmaceutical executives ...
Cached Medicine Technology:Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009 2Deloitte Recap Launches New Solution for Clinical Development 2Deloitte Recap Launches New Solution for Clinical Development 3
... (Penicillin G) inhibits bacterial ... synthesis. Streptomycin belongs to ... inhibits bacterial growth by ... is used for prevention ...
...
Contains 10,000 units of penicillin (base), 10,000 g of streptomycin (base), and 25 g of amphotericin B/ml utilizing penicillin G (sodium salt), streptomycin sulfate, and amphotericin B as Fungizone ...
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility : ...
Medicine Products: